YOUR Therapy Clinic

06/08/2026

A recent Frontiers in Neuroscience case report described temporary improvements in an 80-year-old woman with advanced Alzheimer’s disease after psilocybin administration.

Researchers reported changes across several functions, including speech, social interaction, continence, movement, and memory recall, but they clearly cautioned that this does not prove disease reversal.

The finding is important because Alzheimer’s can leave some abilities inaccessible rather than completely erased, raising questions about whether certain brain networks can be briefly reactivated.

Psilocybin is being studied because it affects serotonin receptors and may influence neuroplasticity, mood, inflammation, and communication between brain regions.

This remains a single-patient case, not a proven treatment, so larger controlled clinical trials are needed before anyone can call it a safe or effective Alzheimer’s therapy.

06/04/2026

Where are you on your journey to true wisdom?

Many people use spirituality to gain something: status, power, attention, or escape.
But real inner peace begins when the constant hunger for “more” starts fading away.

The deepest growth is not becoming superior to others. It is becoming free from the need to prove anything at all.

06/02/2026

If you have ever wondered why this attraction works, here is a comprehensive explanation!!

05/30/2026

The package can be decorated with a pretty bow and sharp edges and people can think “oh wow! What is inside will be fantastic!!” Or the package is wrapped in newspaper and masking tape and people are leery of what may be inside. The gift inside is going to be beautiful regardless, because of who it came from 💝 Just let that sink in 💣

05/30/2026

A new study in Neuropsychopharmacology gave male and female mice a single dose of psilocybin and tracked their social behaviour over seven days.

The effects were completely sex-specific. Females showed increased huddling and hypothermia acutely, enhanced novelty-seeking at 4 hours, then shifted toward preferring familiar social bonds by day 7.

Males showed none of the acute effects, but by 24 hours had reduced anxiety behaviours and increased preference for cage-mates, with novelty-driven dopamine responses in the nucleus accumbens blunted at both 24 hours and 7 days.

The pattern in both sexes suggests psilocybin recalibrates social reward away from novelty and toward meaning, which may explain why people so consistently report reconnecting with family and old friends after psychedelic experiences.

Combined with earlier research showing oestrogen directly modulates psilocybin sensitivity via 5-HT2A receptor availability, the picture is clear: the field can no longer design trials, doses, or integration protocols around male biology alone.

doi:0.1038/s41386-026-02450-x

05/25/2026